NCT00651261
Clinical Trial Information
Trial Number: NCT00651261 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
Study ID:
CALGB-10603
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00651261-D5 | Dataset NCT00651261-D5-Dataset.csv (cytox) is one of 5 datasets associated with PubMed ID 28644114. This dataset contains information that will allow you to reproduce the adverse events table. |
| NCT00651261-D4 | NCT00651261-D4-Dataset.csv (outcome) is one of 5 datasets associated with PubMed ID 28644114. This dataset contains information that will allow you to reproduce the primary analysis. |
| NCT00651261-D3 | NCT00651261-D3-Dataset.csv (consort) is one of 5 datasets associated with PubMed ID 28644114. This dataset contains information that will allow you to reproduce the randomized portion of the consort diagram. |
| NCT00651261-D2 | Dataset NCT00651261-D2-Dataset.csv (screen_pts) is one of 5 datasets associated with PubMed ID 28644114. This dataset contains information that will allow you to reproduce the screening portion of the consort diagram. |
| NCT00651261-D1 | Dataset NCT00651261-D1-Dataset.csv (baseline) is one of 5 datasets associated with PubMed ID 28644114. This dataset contains information that will allow you to reproduce the baseline characteristics table. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®